This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
$0.03000
Share price
0.00%
Change (1 day)
-94.92%
Change (1 year)
Categories
Revenue for Advaxis (ADXS)
Revenue in 2023 (TTM): $0.11 Million USD
According to Advaxis's latest financial reports the company's current revenue (TTM 
) is $0.11 Million USD. In 2022 the company made a revenue of $0.69 Million USD a decrease over the revenue in the year 2021 that were of $3.5 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Advaxis from 2019 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.11 M | -83.53% |
| 2022 | $0.69 M | -80.26% |
| 2021 | $3.5 M | -5.45% |
| 2020 | $3.7 M | 58.87% |
| 2019 | $2.33 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | $0.21 M | 91.01% | 🇺🇸 USA |
 | $1.91 M | 1,576.32% | 🇺🇸 USA |
 | $0.25 B | 223,485.96% | 🇺🇸 USA |